150 related articles for article (PubMed ID: 35367417)
1. Age and sex affect TGFβ2-induced ocular hypertension in C57BL/6J mice.
Sugali CK; Rayana NP; Dai J; Peng M; Mao W
Exp Eye Res; 2022 Jun; 219():109055. PubMed ID: 35367417
[TBL] [Abstract][Full Text] [Related]
2. The application of lentiviral vectors for the establishment of TGFβ2-induced ocular hypertension in C57BL/6J mice.
Peng M; Margetts TJ; Rayana NP; Sugali CK; Dai J; Mao W
Exp Eye Res; 2022 Aug; 221():109137. PubMed ID: 35691374
[TBL] [Abstract][Full Text] [Related]
3. Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma.
Rayana NP; Sugali CK; Dai J; Peng M; Liu S; Zhang Y; Wan J; Mao W
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):7. PubMed ID: 34499703
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes.
Shepard AR; Millar JC; Pang IH; Jacobson N; Wang WH; Clark AF
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2067-76. PubMed ID: 19959644
[TBL] [Abstract][Full Text] [Related]
5. A Novel Mouse Model of TGFβ2-Induced Ocular Hypertension Using Lentiviral Gene Delivery.
Patil SV; Kasetti RB; Millar JC; Zode GS
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805889
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappa beta signaling is required for transforming growth factor Beta-2 induced ocular hypertension.
Hernandez H; Roberts AL; McDowell CM
Exp Eye Res; 2020 Feb; 191():107920. PubMed ID: 31923415
[TBL] [Abstract][Full Text] [Related]
7. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice.
McDowell CM; Luan T; Zhang Z; Putliwala T; Wordinger RJ; Millar JC; John SW; Pang IH; Clark AF
Exp Eye Res; 2012 Jul; 100():65-72. PubMed ID: 22575566
[TBL] [Abstract][Full Text] [Related]
8. ID1 and ID3 are Negative Regulators of TGFβ2-Induced Ocular Hypertension and Compromised Aqueous Humor Outflow Facility in Mice.
Mody AA; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2021 May; 62(6):3. PubMed ID: 33938911
[TBL] [Abstract][Full Text] [Related]
9. Knockout of tissue transglutaminase ameliorates TGFβ2-induced ocular hypertension: A novel therapeutic target for glaucoma?
Raychaudhuri U; Millar JC; Clark AF
Exp Eye Res; 2018 Jun; 171():106-110. PubMed ID: 29535003
[TBL] [Abstract][Full Text] [Related]
10. Effects of Toll-Like Receptor 4 Inhibition on Transforming Growth Factor-β2 Signaling in the Human Trabecular Meshwork.
Sharma TP; Curry S; McDowell CM
J Ocul Pharmacol Ther; 2020 Apr; 36(3):170-178. PubMed ID: 31834824
[No Abstract] [Full Text] [Related]
11. Astragaloside IV Attenuates Ocular Hypertension in a Mouse Model of TGFβ2 Induced Primary Open Angle Glaucoma.
Kasetti RB; Maddineni P; Kodati B; Nagarajan B; Yacoub S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830390
[TBL] [Abstract][Full Text] [Related]
12. Disruption of fibronectin fibrillogenesis affects intraocular pressure (IOP) in BALB/cJ mice.
Faralli JA; Filla MS; McDowell CM; Peters DM
PLoS One; 2020; 15(8):e0237932. PubMed ID: 32822410
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS
J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238
[TBL] [Abstract][Full Text] [Related]
14. A20 Attenuates the Fibrotic Response in the Trabecular Meshwork.
Mzyk P; Zalog EG; McDowell CM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216043
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin reduces IOP in ocular hypertension
Song XY; Chen YY; Liu WT; Cong L; Zhang JL; Zhang Y; Zhang YY
Int J Mol Med; 2022 Jun; 49(6):. PubMed ID: 35417030
[TBL] [Abstract][Full Text] [Related]
16. NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs.
Bastia E; Toris CB; Brambilla S; Galli C; Almirante N; Bergamini MVW; Masini E; Sgambellone S; Unser AM; Ahmed F; Torrejon KY; Navratil T; Impagnatiello F
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):17. PubMed ID: 33704360
[TBL] [Abstract][Full Text] [Related]
17. Smad3 is necessary for transforming growth factor-beta2 induced ocular hypertension in mice.
McDowell CM; Tebow HE; Wordinger RJ; Clark AF
Exp Eye Res; 2013 Nov; 116():419-23. PubMed ID: 24184030
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin extra domain A (FN-EDA) elevates intraocular pressure through Toll-like receptor 4 signaling.
Roberts AL; Mavlyutov TA; Perlmutter TE; Curry SM; Harris SL; Chauhan AK; McDowell CM
Sci Rep; 2020 Jun; 10(1):9815. PubMed ID: 32555351
[TBL] [Abstract][Full Text] [Related]
19. Elevation of intraocular pressure in rodents using viral vectors targeting the trabecular meshwork.
Pang IH; Millar JC; Clark AF
Exp Eye Res; 2015 Dec; 141():33-41. PubMed ID: 26025608
[TBL] [Abstract][Full Text] [Related]
20. Gremlin Induces Ocular Hypertension in Mice Through Smad3-Dependent Signaling.
McDowell CM; Hernandez H; Mao W; Clark AF
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5485-92. PubMed ID: 26284554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
